2
views
0
recommends
+1 Recommend
2 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Increased Lengths of Stay, ICU, and Ventilator Days in Trauma Patients with Asymptomatic COVID-19 Infection

      research-article
      , MD 1 , , , BS 1 , , PhD 1 , , MD 1 , , MD 1
      The American Surgeon
      SAGE Publications
      COVID-19, Trauma, Pandemic, Outcomes

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          The SARS-Cov-2 coronavirus has varying clinical effects—from asymptomatic patients to life-threatening illness and death. At the only Level 1 Trauma Center in a rural state, outcomes appeared worse in trauma patients who tested positive for COVID despite these patients presumably being asymptomatic or only mildly affected before their traumatic event. This study compares all trauma admissions that were COVID-positive to those who were not.

          Methods

          The institutional database was queried for all level 1 and 2 trauma activations from March 2020-July 2021. The analysis consisted of a multivariate regression between COVID-negative and the COVID-positive group controlling for age, injury severity score (ISS), and Glasgow Coma Score (GCS). Outcomes compared were hospital length-of-stay (LOS), ICU LOS, ventilator days, days to discharge to a facility, and in-hospital mortality.

          Results

          Hospital LOS was 2.7 days longer in the COVID-positive group ( P < .0005). ICU LOS was 2.9 days longer for patients admitted to the ICU in the COVID positive-group ( P = .017). Ventilator days were 4.7 days longer for patients requiring mechanical ventilation in the COVID-positive group ( P = .002). Discharge to a post-acute facility required 6.1 more days in the COVID-positive group ( P = .005).

          Conclusion

          Trauma patients presenting positive for COVID-19 are presumed to be asymptomatic before their traumatic event. Despite this, the physiologic toll of trauma combined with the COVID infection causes significantly worse clinical outcomes, including increasing hospital days in this patient population, which continues to tax the already burdened healthcare system.

          Related collections

          Most cited references16

          • Record: found
          • Abstract: found
          • Article: found

          Hematological findings and complications of COVID ‐19

          Abstract COVID‐19 is a systemic infection with a significant impact on the hematopoietic system and hemostasis. Lymphopenia may be considered as a cardinal laboratory finding, with prognostic potential. Neutrophil/lymphocyte ratio and peak platelet/lymphocyte ratio may also have prognostic value in determining severe cases. During the disease course, longitudinal evaluation of lymphocyte count dynamics and inflammatory indices, including LDH, CRP and IL‐6 may help to identify cases with dismal prognosis and prompt intervention in order to improve outcomes. Biomarkers, such high serum procalcitonin and ferritin have also emerged as poor prognostic factors. Furthermore, blood hypercoagulability is common among hospitalized COVID‐19 patients. Elevated D‐Dimer levels are consistently reported, whereas their gradual increase during disease course is particularly associated with disease worsening. Other coagulation abnormalities such as PT and aPTT prolongation, fibrin degradation products increase, with severe thrombocytopenia lead to life‐threatening disseminated intravascular coagulation (DIC), which necessitates continuous vigilance and prompt intervention. So, COVID‐19 infected patients, whether hospitalized or ambulatory, are at high risk for venous thromboembolism, and an early and prolonged pharmacological thromboprophylaxis with low molecular weight heparin is highly recommended. Last but not least, the need for assuring blood donations during the pandemic is also highlighted.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Cardiovascular complications in COVID-19

            Background The coronavirus disease of 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). While systemic inflammation and pulmonary complications can result in significant morbidity and mortality, cardiovascular complications may also occur. Objective This brief report evaluates cardiovascular complications in the setting of COVID-19 infection. Discussion The current COVID-19 pandemic has resulted in over one million infected worldwide and thousands of death. The virus binds and enters through angiotensin-converting enzyme 2 (ACE2). COVID-19 can result in systemic inflammation, multiorgan dysfunction, and critical illness. The cardiovascular system is also affected, with complications including myocardial injury, myocarditis, acute myocardial infarction, heart failure, dysrhythmias, and venous thromboembolic events. Current therapies for COVID-19 may interact with cardiovascular medications. Conclusions Emergency clinicians should be aware of these cardiovascular complications when evaluating and managing the patient with COVID-19.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Increased Mortality and Major Complications in Hip Fracture Care During the COVID-19 Pandemic: A New York City Perspective

              Supplemental Digital Content is Available in the Text.
                Bookmark

                Author and article information

                Journal
                Am Surg
                Am Surg
                spasu
                ASU
                The American Surgeon
                SAGE Publications (Sage CA: Los Angeles, CA )
                0003-1348
                1555-9823
                13 April 2022
                13 April 2022
                : 00031348221082290
                Affiliations
                [1 ]Department of Surgery, Ringgold 12215, universityUniversity of Arkansas for Medical Sciences; , Little Rock, AR, USA
                Author notes
                [*]Garrett N Klutts, Department of Surgery, University of Arkansas for Medical Sciences, 4301 W Markham, Little Rock, AR 72205-7101, USA. Email: gklutts@ 123456uams.edu
                Author information
                https://orcid.org/0000-0001-6313-9198
                Article
                10.1177_00031348221082290
                10.1177/00031348221082290
                9014328
                35416700
                df58ffa3-92c4-431f-bdf8-fad4648c9313
                © The Author(s) 2022

                This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.

                History
                Categories
                SESC Podium Paper
                Custom metadata
                corrected-proof
                ts10

                covid-19,trauma,pandemic,outcomes
                covid-19, trauma, pandemic, outcomes

                Comments

                Comment on this article